RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131 -I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144–152
-
Published:2017-05
Issue:
Volume:77
Page:21-23
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Ronckers Cecile M.ORCID,
Tytgat Lieve,
van den Heuvel-Eibrink Marry M.,
Teepen Jop,
Kremer Leontine C.M.,
Clement Sarah,
van Santen Hanneke M.
Funder
Dutch Cancer Society
Subject
Cancer Research,Oncology